The Epstein-Barr virus (EBV) was the first virus to be discovered that could cause human cancer. Since then, the virus has ...

1 The Epstein-Barr Virus (EBV), known for causing infectious mononucleosis, has been a suspect in the MS mystery for years.

Moderna’s stock jumped on Thursday as the company reported a narrower-than-expected first-quarter loss and looks to launch ...

To date, EBV is the most closely implicated infectious agent to be associated with both MS and SLE. Epidemiological findings show a strong correlation between EBV infection and the risk of ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform ...

The central role of Epstein-Barr virus in causing multiple sclerosis is examined to understand how it triggers the disease and presents new opportunities for treatment “Evidence is mounting that ...

Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine ...

And a breakthrough 2022 paper from Harvard epidemiologist Albert Ascherio found that contracting Epstein Barr Virus increased the risk of developing MS thirtyfold — a finding echoed by the UCSF study, ...

Researchers have developed a new and unique blood test to measure the immune response to the Epstein Barr Virus (EBV) which is the leading risk factor for developing multiple sclerosis (MS).

Welcome to the Moderna's first-quarter 2024 conference call. [Operator instructions] Please be advised, today's conference is ...

The authors suggest that EBV is a cofactor in MS and SLE susceptibility, and it is likely that, in combination with genetic susceptibility, the strength of the cellular and humoral immune response ...

Epstein-Barr virus (EBV) is a herpes virus otherwise known of as human herpesvirus 4 (HHV-4). It is most well known for causing glandular fever but research shows that EBV infection is also linked ...